Paired box gene 8: Difference between revisions
Jump to navigation
Jump to search
Created page with "'''Paired box gene 8''', commonly known by the abbreviation '''PAX8''', is a commonly used immunostain in gynecologic pathology and genitourinary pathology. ==Tum..." |
|||
| Line 6: | Line 6: | ||
*[[Renal oncocytoma]]s ~ 80%.<ref name=pmid21552115/> | *[[Renal oncocytoma]]s ~ 80%.<ref name=pmid21552115/> | ||
*High-grade [[ovarian serous carcinoma]]s ~ 99%.<ref name=pmid21552115/> | *High-grade [[ovarian serous carcinoma]]s ~ 99%.<ref name=pmid21552115/> | ||
*Nonserous epithelial [[ovarian tumours|ovarian neoplasms]] ~ 70%.<ref name=pmid21552115/> | |||
*[[Endometrial carcinoma]]s ~ 98%.<ref name=pmid21552115/> | *[[Endometrial carcinoma]]s ~ 98%.<ref name=pmid21552115/> | ||
Revision as of 17:32, 15 June 2015
Paired box gene 8, commonly known by the abbreviation PAX8, is a commonly used immunostain in gynecologic pathology and genitourinary pathology.
Tumours with positive staining
- Thyroid tumours ~ 90%.[1]
- Renal cell carcinomas ~ 90%.[1]
- Renal oncocytomas ~ 80%.[1]
- High-grade ovarian serous carcinomas ~ 99%.[1]
- Nonserous epithelial ovarian neoplasms ~ 70%.[1]
- Endometrial carcinomas ~ 98%.[1]